Basic/Clinical Science Session

Diabetic Kidney Disease: New Tricks for Old Targets

October 27, 2018 | 02:00 PM - 04:00 PM

Location: 5A, San Diego Convention Center

Session Description

Recent studies demonstrate that interventions targeting the innate immune system have unanticipated benefits in diabetic kidney disease (DKD). Understanding the molecular mechanisms underpinning such responses may provide novel insights into the pathogenesis of disease and therapeutic development.

Learning Objective(s)

  • discuss the potential of innate immune targets in DKD
  • describe the role of inflammation and its resolution as a therapeutic goal in DKD

Learning Pathway(s)

  • Diabetes and Metabolism


  • Celine C. Berthier, PhD
  • Matthew D. Griffin, MBChB


  • Inflammasomes in DKD
    02:00 PM - 02:30 PM
    Jun Wada, MD, PhD
  • Nox5 Accelerates Renal Injury in Diabetic Nephropathy
    02:30 PM - 03:00 PM
    Karin Jandeleit-Dahm, MD, PhD
  • Monocyte Chemoattractant Protein 1 as a Target in DKD
    03:00 PM - 03:30 PM
    Thomas J. Schall, PhD
  • Mesenchymal Stem Cell Therapies in DKD: The NEPHSTROM Experience
    03:30 PM - 04:00 PM
    Norberto Perico, MD